Internal Medicine · Rosemead, CA
NPI
1598784340
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3105 del Mar Ave
Rosemead, CA, 91770
Phone (626) 280-8897
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,161 services
Medicare patients, 2024
137
Average age 77
Drug cost, 2024
$2.1M
20,838 prescriptions
Company payments, 2025
$932
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hong Liang was code 99213 (office e&m - established), 730 times for 118 patients. In total Hong Liang billed 1,161 services in 13 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 730 | 118 | $72.80 | $53K |
| 99457 E&M - Miscellaneous | Office | 159 | 27 | $42.75 | $6,798 |
| 99454 E&M - Miscellaneous | Office | 141 | 23 | $43.95 | $6,198 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 96 | 96 | $140.14 | $13K |
By year: 2022 $94K for 1,297 services; 2023 $105K for 1,610 services; 2024 $83K for 1,161 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hong Liang prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,789 prescriptions and refills. In total Hong Liang wrote 20,838 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,789 | 4,585 | 502 | $19K |
| Calcitriol Generic | 1,087 | 2,750 | 311 | $28K |
| Amlodipine Besylate Generic | 1,045 | 2,531 | 264 | $6,577 |
| Metformin Hcl Generic | 1,022 | 2,673 | 266 | $7,837 |
| Losartan Potassium Generic | 842 | 2,222 | 229 | $10K |
| Icosapent Ethyl Generic | 828 | 2,097 | 315 | $358K |
| Montelukast Sodium Generic | 618 | 1,498 | 281 | $6,166 |
| Rosuvastatin Calcium Generic | 601 | 1,423 | 191 | $7,238 |
| Olmesartan Medoxomil Generic | 577 | 1,371 | 164 | $7,835 |
| Vascepa Icosapent Ethyl | 572 | 791 | 165 | $255K |
| Metoprolol Succinate Generic | 388 | 951 | 110 | $6,652 |
| Clopidogrel Clopidogrel Bisulfate | 359 | 838 | 108 | $3,982 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 352 | 909 | 95 | $5,935 |
| Alendronate Sodium Generic | 344 | 810 | 89 | $2,576 |
| Zolpidem Tartrate Generic | 327 | 355 | 123 | $916 |
Brand drugs: 2,171 claims; generic drugs: 18,559 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hong Liang $932 ($932 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $201.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $201 |
| Merck Sharp & Dohme LLC MRK | 8 | $179 |
| Novo Nordisk Inc NVO | 2 | $147 |
| Amgen Inc. AMGN | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $84.85 |
| GlaxoSmithKline, LLC. GSK | 2 | $48.59 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.15 |
| Abbvie Inc. ABBV | 1 | $21.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.